These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 11158479
1. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"? Thébaud B, Lacaze-Masmonteil T, Watterberg K. Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479 [No Abstract] [Full Text] [Related]
2. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Watterberg KL, American Academy of Pediatrics. Committee on Fetus and Newborn. Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899 [Abstract] [Full Text] [Related]
4. Postnatal corticosteroids for preterm infants--do what we say, not what we do. Jobe AH. N Engl J Med; 2004 Mar 25; 350(13):1349-51. PubMed ID: 15044647 [No Abstract] [Full Text] [Related]
5. Neurological adverse effects of early postnatal dexamethasone in very preterm infants. Baud O, Zupan V, Lacaze-Masmonteil T, Dehan M. Arch Dis Child Fetal Neonatal Ed; 1999 Mar 25; 80(2):F159. PubMed ID: 10325800 [No Abstract] [Full Text] [Related]
9. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants. Warmerdam LA, van Wezel-Meijler G, de Vries LS, Groenendaal F, Steggerda SJ. Neonatology; 2023 Mar 25; 120(5):615-623. PubMed ID: 37379806 [Abstract] [Full Text] [Related]
10. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Williams AF. Arch Dis Child; 1993 Sep 25; 69(3 Spec No):331. PubMed ID: 8215580 [No Abstract] [Full Text] [Related]
11. Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? Eichenwald EC, Stark AR. Arch Dis Child Fetal Neonatal Ed; 2007 Sep 25; 92(5):F334-7. PubMed ID: 17712183 [Abstract] [Full Text] [Related]
12. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Ng PC. Arch Dis Child; 1993 Mar 25; 68(3 Spec No):330-6. PubMed ID: 8466274 [No Abstract] [Full Text] [Related]
13. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Doyle LW, Ehrenkranz RA, Halliday HL. Neonatology; 2010 Mar 25; 98(3):217-24. PubMed ID: 20389126 [Abstract] [Full Text] [Related]
15. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH. N Engl J Med; 2004 Mar 25; 350(13):1304-13. PubMed ID: 15044641 [Abstract] [Full Text] [Related]
16. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia. Lim G, Lee BS, Choi YS, Park HW, Chung ML, Choi HJ, Kim EA, Kim KS. Pediatr Neonatol; 2015 Aug 25; 56(4):261-7. PubMed ID: 25649722 [Abstract] [Full Text] [Related]